SMITH IAN F — SEC Form 4 filings

SEC reporting owner CIK 1197032. 21 Form 4 filings on record with FilingPulse; latest filed 2026-07-07.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2024-04-05 to 2026-07-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Solid Biosciences Inc. (SLDB)Director1327
Stoke Therapeutics, Inc. (STOK)Chief Executive Officer, Director46
Foghorn Therapeutics Inc. (FHTX)Director33
Odyssey Therapeutics, Inc. (ODTX)Director11

Form 4 filings — SMITH IAN F

FiledFormIssuerReported transactionsSource
2026-07-074Solid Biosciences Inc. (SLDB)Option exercise (M): 3,440 · Option exercise (M): 3,440 (derivative) @ $0EDGAR
2026-06-254Foghorn Therapeutics Inc. (FHTX)Grant/award (A): 28,000 (derivative) @ $4.08EDGAR
2026-06-114Solid Biosciences Inc. (SLDB)Grant/award (A): 77,500 (derivative) @ $0EDGAR
2026-05-114Odyssey Therapeutics, Inc. (ODTX)Grant/award (A): 27,393 (derivative) @ $0EDGAR
2026-04-024Solid Biosciences Inc. (SLDB)Option exercise (M): 3,441 · Option exercise (M): 3,441 (derivative) @ $0EDGAR
2026-02-194Stoke Therapeutics, Inc. (STOK)Grant/award (A): 193,000 (derivative) @ $0 · Grant/award (A): 129,000 (derivative) @ $0EDGAR
2026-01-074Solid Biosciences Inc. (SLDB)Option exercise (M): 4,573 · Grant/award (A): 18,012 (derivative) @ $0 · Grant/award (A): 13,761 (derivative) @ $0 · Option exercise (M): 4,573 (derivative) @ $0EDGAR
2025-10-144Stoke Therapeutics, Inc. (STOK)Grant/award (A): 570,000 (derivative) @ $0 · Grant/award (A): 380,000 (derivative) @ $0EDGAR
2025-10-074Solid Biosciences Inc. (SLDB)Option exercise (M): 4,573 · Option exercise (M): 4,573 (derivative) @ $0EDGAR
2025-07-084Solid Biosciences Inc. (SLDB)Option exercise (M): 4,573 · Option exercise (M): 4,573 (derivative) @ $0EDGAR
2025-06-174Foghorn Therapeutics Inc. (FHTX)Grant/award (A): 25,000 (derivative) @ $4.79EDGAR
2025-06-134Solid Biosciences Inc. (SLDB)Grant/award (A): 77,500 (derivative) @ $0EDGAR
2025-04-084Solid Biosciences Inc. (SLDB)Option exercise (M): 4,574 · Option exercise (M): 4,574 (derivative) @ $0EDGAR
2025-03-204Stoke Therapeutics, Inc. (STOK)Grant/award (A): 238,420 (derivative) @ $0EDGAR
2025-01-074Solid Biosciences Inc. (SLDB)Option exercise (M): 3,255 · Option exercise (M): 3,255 (derivative) @ $0 · Grant/award (A): 22,148 (derivative) @ $0 · Grant/award (A): 18,293 (derivative) @ $0EDGAR
2024-10-044Solid Biosciences Inc. (SLDB)Option exercise (M): 3,255 · Option exercise (M): 3,255 (derivative) @ $0EDGAR
2024-07-054Solid Biosciences Inc. (SLDB)Option exercise (M): 3,255 · Option exercise (M): 3,255 (derivative) @ $0EDGAR
2024-06-284Foghorn Therapeutics Inc. (FHTX)Grant/award (A): 16,000 (derivative) @ $5.52EDGAR
2024-06-134Solid Biosciences Inc. (SLDB)Grant/award (A): 34,400 (derivative) @ $0EDGAR
2024-06-074Stoke Therapeutics, Inc. (STOK)Grant/award (A): 7,639 (derivative) @ $0EDGAR
2024-04-054Solid Biosciences Inc. (SLDB)Option exercise (M): 3,256 · Option exercise (M): 3,256 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1197032 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →